Results: 1-17 |
Results: 17

Authors: Shah, MA Schwartz, GK
Citation: Ma. Shah et Gk. Schwartz, Cell cycle-mediated drug resistance: An emerging concept in cancer therapy, CLIN CANC R, 7(8), 2001, pp. 2168-2181

Authors: Jung, CP Motwani, MV Schwartz, GK
Citation: Cp. Jung et al., Flavopiridol increases sensitization to gemcitabine in human gastrointestinal cancer cell lines and correlates with down-regulation of ribonucleotidereductase M2 subunit, CLIN CANC R, 7(8), 2001, pp. 2527-2536

Authors: Hsueh, CT Wu, YC Schwartz, GK
Citation: Ct. Hsueh et al., UCN-01 suppresses E2F-1 mediated by ubiquitin-proteasome-dependent degradation, CLIN CANC R, 7(3), 2001, pp. 669-674

Authors: O'Reilly, EM Stuart, KE Sanz-Altamira, PM Schwartz, GK Steger, CM Raeburn, L Kemeny, NE Kelsen, DP Saltz, LB
Citation: Em. O'Reilly et al., A Phase II study of irinotecan in patients with advanced hepatocellular carcinoma, CANC CYTOP, 91(1), 2001, pp. 101-105

Authors: O'Reilly, EM Stuart, KE Sanz-Altamira, PM Schwartz, GK Steger, CM Raeburn, L Kemeny, NE Kelsen, DP Saltz, LB
Citation: Em. O'Reilly et al., A Phase II study of irinotecan in patients with advanced hepatocellular carcinoma, CANCER, 91(1), 2001, pp. 101-105

Authors: Kaubisch, A Schwartz, GK
Citation: A. Kaubisch et Gk. Schwartz, Cyclin-dependent kinase and protein kinase C inhibitors: A novel class of antineoplastic agents in clinical development, CANCER J, 6(4), 2000, pp. 192-212

Authors: Shah, MA Schwartz, GK
Citation: Ma. Shah et Gk. Schwartz, The relevance of drug sequence in combination chemotherapy, DRUG RESIST, 3(6), 2000, pp. 335-356

Authors: Koutcher, JA Motwani, M Zakian, KL Li, XK Matei, C Dyke, JP Ballon, D Yoo, HH Schwartz, GK
Citation: Ja. Koutcher et al., The in vivo effect of bryostatin-1 on paclitaxel-induced tumor growth, mitotic entry, and blood flow, CLIN CANC R, 6(4), 2000, pp. 1498-1507

Authors: Motwani, M Li, XK Schwartz, GK
Citation: M. Motwani et al., Flavopiridol, a cyclin-dependent kinase inhibitor, prevents spindle inhibitor-induced endoreduplication in human cancer cells, CLIN CANC R, 6(3), 2000, pp. 924-932

Authors: Schwartz, GK Ilson, D Saltz, L O'Reilly, E Tong, W Maslak, P Werner, J Perkins, P Stoltz, M Kelsen, D
Citation: Gk. Schwartz et al., Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma, J CL ONCOL, 19(7), 2000, pp. 1985-1992

Authors: Hsueh, CT Chiu, CF Kelsen, DP Schwartz, GK
Citation: Ct. Hsueh et al., Selective inhibition of cyclooxygenase-2 enhances mitomycin-C-induced apoptosis, CANC CHEMOT, 45(5), 2000, pp. 389-396

Authors: Li, XK Motwani, M Tong, W Bornmann, W Schwartz, GK
Citation: Xk. Li et al., Huanglian, a Chinese herbal extract, inhibits cell growth by suppressing the expression of cyclin B1 and inhibiting CDC2 kinase activity in human cancer cells, MOLEC PHARM, 58(6), 2000, pp. 1287-1293

Authors: Motwani, M Delohery, TM Schwartz, GK
Citation: M. Motwani et al., Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cells, CLIN CANC R, 5(7), 1999, pp. 1876-1883

Authors: Schwartz, GK Harstrick, A Baron, MG
Citation: Gk. Schwartz et al., Raltitrexed (Tomudex (TM)) in combination with 5-fluorouracil for the treatment of patients with advanced colorectal cancer: Preliminary results fromphase I clinical trials, EUR J CANC, 35, 1999, pp. S9-S13

Authors: Fata, F O'Reilly, E Ilson, D Pfister, D Leffel, D Kelsen, DP Schwartz, GK Casper, ES
Citation: F. Fata et al., Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face, CANCER, 86(10), 1999, pp. 2034-2037

Authors: Saltz, LB Spriggs, D Schaaf, LJ Schwartz, GK Ilson, D Kemeny, N Kanowitz, J Steger, C Eng, M Albanese, P Semple, D Hanover, CK Elfring, GL Miller, LL Kelsen, D
Citation: Lb. Saltz et al., Phase I clinical and pharmacologic study of weekly cisplatin combined withweekly irinotecan in patients with advanced solid tumors, J CL ONCOL, 16(12), 1998, pp. 3858-3865

Authors: Donadio, AC Dragnev, KH Schwartz, GK
Citation: Ac. Donadio et al., Thymoma associated with syndrome of inappropriate antidiuretic hormone secretion and myasthenia gravis, SOUTH MED J, 91(3), 1998, pp. 278-279
Risultati: 1-17 |